Cosmos HealthvsJohnson & Johnson

COSM and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

COSM

Cosmos Health Inc.

$2.93

Value –

-0.78%
COSM's page

Over the last year, with dividends, COSM moved -79.1% and JNJ +36.0%. Dividend yield: COSM none, JNJ 1.99%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    COSM–

    JNJ$641B

  • Revenue, 12 months

    COSM$74M

    JNJ$99.3B

    JNJ is 1,347 times COSM

  • Net income, 12 months

    COSM-$24M

    JNJ$16.1B

  • Operating margin

    COSM-24.9%

    JNJ–

  • ROIC

    COSM-50.9%

    JNJ12.4%

    63.3 points apart

  • P/E

    COSM–

    JNJ39.8

  • Dividend yield

    COSM0.0%

    JNJ2.0%

    2.0 points apart

  • 5-year return

    COSM-96.5%

    JNJ+88.3%

    184.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

COSM-96.5%

JNJ+88.3%

010020020222023202420252026
Returns by period
PeriodCOSMWith dividendsJNJWith dividends
1 year since November 18, 2025-79.1%Price -79.1%+36.0%Price +33.0%
3 years since November 17, 2023-86.4%-48.6% a yearPrice -86.4%+93.4%+24.6% a yearPrice +77.6%
5 years since November 18, 2021-96.5%-48.9% a yearPrice -96.5%+88.3%+13.5% a yearPrice +63.8%
10 years since November 21, 2016-97.1%-29.8% a yearPrice -97.1%+201.4%+11.7% a yearPrice +131.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

COSMCosmos HealthJNJJohnson & Johnson

Valuation

COSMJNJ
Valuation
Price$2.93$265.93
Market value–$641B
Enterprise value (EV)–$668B
P/E–39.8
P/E, 5-year median–21.9
P/B–7.9
EV/EBIT–37.7
Free cash flow yield–3.2%

Results and growth

COSMJNJ
Results and growth
Revenue, 12 months$74M$99.3B
Net income, 12 months-$24M$16.1B
Free cash flow, 12 months-$9.9M$20.6B
Earnings per share, 12 months-$0.64$6.59
Revenue growth, year on year19.9%6.1%
Revenue growth a year, past+3.3%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

COSMJNJ
Margins and returns on capital
Gross margin10.3%67.6%
Operating margin-24.9%–
Net margin-33.1%16.2%
ROIC-50.9%12.4%
ROE-112.6%19.7%

Balance sheet

COSMJNJ
Balance sheet
Cash$1.8M$17.2B
Total debt–$44.7B
Net debt / EBITDA–1.1
Interest cover-7.8×18.0×

Dividends and buybacks

COSMJNJ
Dividends and buybacks
Dividend yield–2.0%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: COSM or JNJ

Didn't find what you were looking for?

Ask us
How did COSM and JNJ stock do over the last 10 years?

Since November 21, 2016, COSM's price moved -97.1% and JNJ's +131.3%. With dividends: COSM -97.1% (-29.8% a year), JNJ +201.4% (+11.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, COSM or JNJ?

The dividend yield at today's price is none for Cosmos Health and 1.99% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

Which has the higher profit margins, Cosmos Health or Johnson & Johnson?

Over the last twelve months, the net margin was -33.1% for Cosmos Health and 16.2% for Johnson & Johnson, and the operating margin -24.9% and –. Revenue was $74M and $99.3B.

Which is the better investment, Cosmos Health or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.